来自 瑞典 的医学专家被标记为研究 胸腺瘤 的临床试验的研究者
总计11个结果
-
Andreas Hallqvist, MD PhD见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04530708 (副研究员)
- NCT04822077 (副研究员)
-
Anna Bäck, PhD见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04822077 (副研究员)
-
Annica Ravn-Fischer, MD phD见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04822077 (副研究员)
-
Erik Lundin, MD见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04822077 (副研究员)
-
Hillevi Rylander, MD见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04530708 (副研究员)
- NCT04822077 (副研究员)
-
Jan Nyman, Ass prof见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04530708 (首席研究员)
- NCT04822077 (首席研究员)
-
Jens Engleson, MD见于:
- Västra Götaland、Gothenburg、Department of Oncology, Sahlgrenska University Hospital
试验:- NCT04822077 (副研究员)
-
Michael Gubanski, MD PhD见于:
- Stockholm County、Stockholm、Department of Oncology, Karolinska University Hospital
试验:- NCT04822077 (副研究员)
-
Mikael Johansson, MD PhD见于:
- Norrland、Umeå、Department of Oncology, Norrlands Universitetssjukhus
试验:- NCT04822077 (首席研究员)
-
Per Bergström, MD见于:
- Norrland、Umeå、Department of Oncology, Norrlands Universitetssjukhus
试验:- NCT04822077 (副研究员)
-
Signe Friesland, MD PhD见于:
- Stockholm County、Stockholm、Department of Oncology, Karolinska University Hospital
试验:- NCT04530708 (首席研究员)
- NCT04822077 (首席研究员)